OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Remdesivir
Ahmed H. Bakheit, Hany W. Darwish, Ibrahim A. Darwısh, et al.
Profiles of drug substances, excipients, and related methodology (2023), pp. 71-108
Open Access | Times Cited: 16
Ahmed H. Bakheit, Hany W. Darwish, Ibrahim A. Darwısh, et al.
Profiles of drug substances, excipients, and related methodology (2023), pp. 71-108
Open Access | Times Cited: 16
Showing 16 citing articles:
New perspective of small-molecule antiviral drugs development for RNA viruses
Shasha Li, Huixia Li, Ruiya Lian, et al.
Virology (2024) Vol. 594, pp. 110042-110042
Closed Access | Times Cited: 8
Shasha Li, Huixia Li, Ruiya Lian, et al.
Virology (2024) Vol. 594, pp. 110042-110042
Closed Access | Times Cited: 8
Navigating the Complex Landscape of Ebola Infection Treatment: A Review of Emerging Pharmacological Approaches
Francisca Almeida-Pinto, Rui Pinto, João Rocha
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 1, pp. 21-55
Open Access | Times Cited: 7
Francisca Almeida-Pinto, Rui Pinto, João Rocha
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 1, pp. 21-55
Open Access | Times Cited: 7
Evidence-Based Guidance for One Health Preparedness, Prevention, and Response Strategies to Marburg Virus Disease Outbreaks
Claude Mambo Muvunyi, Jean Claude Semuto Ngabonziza, Noella Bigirimana, et al.
Diseases (2024) Vol. 12, Iss. 12, pp. 309-309
Open Access | Times Cited: 7
Claude Mambo Muvunyi, Jean Claude Semuto Ngabonziza, Noella Bigirimana, et al.
Diseases (2024) Vol. 12, Iss. 12, pp. 309-309
Open Access | Times Cited: 7
Analysis of Antiviral Drug Usage in COVID-19 Fatalities: A Retrospective Study
Mohamed Hassan Dehghan, Mahdis Parhizgar, Delaram Fadaee Heydarabadi, et al.
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access
Mohamed Hassan Dehghan, Mahdis Parhizgar, Delaram Fadaee Heydarabadi, et al.
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access
Effectiveness and Tolerability of Dual Antiviral Therapy in Immunosuppressed Patients with Protracted SARS-CoV-2 Infection
Giovanna Travi, Francesco Peracchi, Marco Merli, et al.
Infectious Disease Reports (2025) Vol. 17, Iss. 2, pp. 17-17
Open Access
Giovanna Travi, Francesco Peracchi, Marco Merli, et al.
Infectious Disease Reports (2025) Vol. 17, Iss. 2, pp. 17-17
Open Access
Treatment of Ebola Virus Disease: From Serotherapy to the Use of Monoclonal Antibodies
Д. Н. Щербаков, А. А. Исаева, Egor A. Mustaev
Antibodies (2025) Vol. 14, Iss. 1, pp. 22-22
Open Access
Д. Н. Щербаков, А. А. Исаева, Egor A. Mustaev
Antibodies (2025) Vol. 14, Iss. 1, pp. 22-22
Open Access
Repurposing expired Remdesivir as a sustainable anti-corrosion agent for plain steel in HCl medium: Insights from electrochemical and molecular dynamics studies
Ismat H. Ali, Ruhollah Sharifi, Ali Asghar Javidparvar, et al.
Journal of Industrial and Engineering Chemistry (2025)
Open Access
Ismat H. Ali, Ruhollah Sharifi, Ali Asghar Javidparvar, et al.
Journal of Industrial and Engineering Chemistry (2025)
Open Access
Efficacy and safety of antiviral treatments for symptomatic COVID-19 outpatients: network meta-analysis and budget impact analysis
Giacomo Berti, Daniele Mengato, Honoria Ocagli, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Giacomo Berti, Daniele Mengato, Honoria Ocagli, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Unlocking the potential of remdesivir: innovative approaches to drug delivery
Maie S. Taha, Ahsan R. Akram, Ghada A. Abdelbary
Drug Delivery and Translational Research (2025)
Open Access
Maie S. Taha, Ahsan R. Akram, Ghada A. Abdelbary
Drug Delivery and Translational Research (2025)
Open Access
Real life experience on the use of Remdesivir in patients admitted to COVID-19 in two referral Italian hospital: a propensity score matched analysis
Nicola Veronese, Francesco Di Gennaro, Luisa Frallonardo, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Nicola Veronese, Francesco Di Gennaro, Luisa Frallonardo, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
VIRAL DISEASES AND THE ENVIRONMENT RELATIONSHIP
Caio Gonçalves do Amaral, Eduardo Pinto André, Eduardo Maffud Cilli, et al.
Environmental Pollution (2024), pp. 124845-124845
Closed Access | Times Cited: 3
Caio Gonçalves do Amaral, Eduardo Pinto André, Eduardo Maffud Cilli, et al.
Environmental Pollution (2024), pp. 124845-124845
Closed Access | Times Cited: 3
Neurological side effects and drug interactions of antiviral compounds against SARS‐CoV‐2
Tamar Akhvlediani, Raphaël Bernard‐Valnet, Sara P. Dias, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 12, pp. 3904-3912
Closed Access | Times Cited: 6
Tamar Akhvlediani, Raphaël Bernard‐Valnet, Sara P. Dias, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 12, pp. 3904-3912
Closed Access | Times Cited: 6
A potent and broad‐spectrum neutralizing nanobody for SARS‐CoV‐2 viruses, including all major Omicron strains
Hebang Yao, Hongyang Wang, Zhaoyong Zhang, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 4
Hebang Yao, Hongyang Wang, Zhaoyong Zhang, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 4
Computational and experimental investigation on functional monomer selection for a novel molecularly imprinting polymer of remdesivir
Hilda Aprilia Wisnuwardhani, Slamet Ibrahim, Rino R. Mukti, et al.
Journal of Molecular Liquids (2024), pp. 126023-126023
Closed Access | Times Cited: 1
Hilda Aprilia Wisnuwardhani, Slamet Ibrahim, Rino R. Mukti, et al.
Journal of Molecular Liquids (2024), pp. 126023-126023
Closed Access | Times Cited: 1
Remdesivir in Severe Cases of COVID-19 Infection
Alberto Boretti
Current Organocatalysis (2024) Vol. 11, Iss. 4, pp. 273-278
Closed Access
Alberto Boretti
Current Organocatalysis (2024) Vol. 11, Iss. 4, pp. 273-278
Closed Access
Biocompatible, controlled-release remdesivir-loaded liposomes tackling the telomerase activity of Non-Small cell lung cancer cells: Preparation, characterization, in vitro biological evaluation, and molecular docking analysis
Hadeer Soudan, Mahmoud E. Soliman, Ahmed M. R. Fath El‐Bab, et al.
Current Research in Biotechnology (2024), pp. 100256-100256
Open Access
Hadeer Soudan, Mahmoud E. Soliman, Ahmed M. R. Fath El‐Bab, et al.
Current Research in Biotechnology (2024), pp. 100256-100256
Open Access
The Ignored Psychiatric Aspect of Chloroquine in the COVID-19 Outbreak Period: A Narrative Review Study
Mahsa Kamali, Marzieh Azizi, Forouzan Elyasi
Iranian Journal of Psychiatry and Behavioral Sciences (2023) Vol. 17, Iss. 3
Open Access
Mahsa Kamali, Marzieh Azizi, Forouzan Elyasi
Iranian Journal of Psychiatry and Behavioral Sciences (2023) Vol. 17, Iss. 3
Open Access
Remdesivir may hinder the function of Recombination Activating Gene-1 (RAG1)
M. Lakshmanan, Ali H Shabeer
Medical Hypotheses (2023) Vol. 182, pp. 111228-111228
Closed Access
M. Lakshmanan, Ali H Shabeer
Medical Hypotheses (2023) Vol. 182, pp. 111228-111228
Closed Access
